EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis

Zheni Stavre iD, Jung-Min Kim iD, Yeon-Suk Yang, Kerstin Nündel iD, Sachin Chaugule iD, Tadatoshi Sato, Kwang Hwan Park iD, Guangping Gao iD, Ellen M Gravallese iD, Jae-Hyuck Shim iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2218019120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Zheni Stavre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology, University of Massachusetts Chan Medical School, Worcester, MA 01605. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Bone Resorption. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to systemic and articular bone loss by activating bone resorption and suppressing bone formation. Despite current therapeutic agents, inflammation-induced bone loss in RA continues to be a significant clinical problem due to joint deformity and lack of articular and systemic bone repair. Here, we identify the suppressor of bone formation, Schnurri-3 (SHN3), as a potential target to prevent bone loss in RA. SHN3 expression in osteoblast-lineage cells is induced by proinflammatory cytokines. Germline deletion or conditional deletion of Shn3 in osteoblasts limits articular bone erosion and systemic bone loss in mouse models of RA. Similarly, silencing of SHN3 expression in these RA models using systemic delivery of a bone-targeting recombinant adenoassociated virus protects against inflammation-induced bone loss. In osteoblasts, TNF activates SHN3 via ERK MAPK-mediated phosphorylation and, in turn, phosphorylated SHN3 inhibits WNT/β-catenin signaling and up-regulates RANKL expression. Accordingly, knock-in of a mutation in Shn3 that fails to bind ERK MAPK promotes bone formation in mice overexpressing human TNF due to augmented WNT/β-catenin signaling. Remarkably, Shn3-deficient osteoblasts are not only resistant to TNF-induced suppression of osteogenesis, but also down-regulate osteoclast development. Collectively, these findings demonstrate SHN3 inhibition as a promising approach to limit bone loss and promote bone repair in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidBone ResorptionMiceHumansAnimalsbeta CateninDNA-Binding ProteinsBone and BonesOsteoblastsOsteogenesisInflammationOsteoclasts

Stichwörter der Autor:innen

Schnurri-3WNT signalingosteoblastosteoclastrheumatoid arthritis

Substanzen

beta CateninDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Medicine, Division of Rheumatology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul 03722, South Korea.
  • Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605.

ORCID-Profile: Zheni Stavre, Jung-Min Kim, Kerstin Nündel, Sachin Chaugule, Kwang Hwan Park, Guangping Gao, Ellen M Gravallese, Jae-Hyuck Shim

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS
  • NICHD NIH HHS
  • NINDS NIH HHS
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Foundation for the National Institutes of Health

Zitieren

APA

Stavre, Z., Kim, J. M., Yang, Y. S., Nündel, K., Chaugule, S., Sato, T., Park, K. H., Gao, G., Gravallese, E. M., & Shim, J. H. (2023). Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2218019120

Vancouver

Stavre Z, Kim JM, Yang YS, Nündel K, Chaugule S, Sato T, et al. Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2218019120

BibTeX
@article{Stavre2023,
  author = {Stavre, Zheni and Kim, Jung-Min and Yang, Yeon-Suk and Nündel, Kerstin and Chaugule, Sachin and Sato, Tadatoshi and Park, Kwang Hwan and Gao, Guangping and Gravallese, Ellen M and Shim, Jae-Hyuck},
  title = {Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2218019120}
}
Kostenlos starten →